EFFICACY OF GALCANEZUMAB IN PATIENTS WHO FAILED TO RESPOND TO PREVENTIVES PREVIOUSLY: RESULTS FROM EVOLVE-1, EVOLVE-2 AND REGAIN STUDIES

被引：0
|
作者：
Zhang, Q. [1 ]
Ruff, D. D. [1 ]
Pearlman, E. M. [2 ]
Govindan, S. [3 ]
Aurora, S. [4 ]
机构：
[1] Eli Lilly & Co, Stat Neurosci LTC, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Migraine Headache, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Med Writing, LCCI Biometr, Bangalore, Karnataka, India
[4] Eli Lilly & Co, Gakanezumab Launch, Indianapolis, IN 46285 USA
来源：
CEPHALALGIA | 2018年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTIS2018-0
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [31] 100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies (vol 58, pg 1347, 2018)
    Rosen, N.
    Pearlman, E.
    Ruff, D.
    Nagy, Jim A.
    HEADACHE, 2019, 59 (08): : 1428 - 1428
  • [32] Changes in patient functioning and disability: results from two phase 3 double-blind placebo-controlled clinical trials evaluating galcanezumab for episodic migraine prevention (EVOLVE-1 and EVOLVE-2)
    Ford, Janet H.
    Ayer, David W.
    Zhang, Qi
    Carter, Jeffrey N.
    Skljarevski, Vladimir
    Aurora, Sheena K.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [33] Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
    Skljarevski, Vladimir
    Matharu, Manjit
    Millen, Brian A.
    Ossipov, Michael H.
    Kim, Byung-Kun
    Yang, Jyun Yan
    CEPHALALGIA, 2018, 38 (08) : 1442 - 1454
  • [34] Persistence of Effect of Galcanezumab in Patients with Episodic or Chronic Migraine: Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1,-2 and REGAIN Studies
    Aurora, S.
    Zhang, Q.
    HEADACHE, 2018, 58 : 177 - 178
  • [35] EFFICACY AND TOLERABILITY OF CELECOXIB IN PATIENTS WITH OSTEOARTHRITIS WHO PREVIOUSLY DID NOT RESPOND TO OR DID NOT TOLERATE NAPROXEN AND IBUPROFEN: RESULTS FROM 2 IDENTICALLY DESIGNED RANDOMIZED TRIALS
    Asmus, M. J.
    Essex, M. N.
    Brown, P. Bhadra
    Mallen, S. R.
    OSTEOARTHRITIS AND CARTILAGE, 2013, 21 : S253 - S253
  • [36] Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial
    Coppens, Michiel
    Synhorst, David
    Eikelboom, John W.
    Yusuf, Salim
    Shestakovska, Olga
    Connolly, Stuart J.
    EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1856 - 1863
  • [37] Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the phase 3 evolve-ms-1 study
    Wray, S.
    Singer, B.
    Drulovic, J.
    Chen, H.
    Hanna, J.
    Lyons, J.
    Bergh, F. Then
    Negroski, D.
    Kapadia, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 214 - 215
  • [38] Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 Study
    Singer, B. A.
    Drulovic, J.
    Chen, H.
    Lyons, J.
    Then Bergh, F.
    Negroski, D.
    Kapadia, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 619 - 620
  • [39] Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
    Singer, B. A.
    Drulovic, J.
    Negroski, D.
    Selmaj, K.
    Bergh, F. Then
    Scaramozza, M.
    Castro-Borrero, W.
    Adair, H.
    Chen, H.
    Levin, S.
    Shankar, S. L.
    Wray, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 625 - 626
  • [40] Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
    Singer, Barry A.
    Arnold, Douglas L.
    Drulovic, Jelena
    Freedman, Mark S.
    Gold, Ralf
    Gudesblatt, Mark
    Jasinska, Elzbieta
    Laganke, Christopher C.
    Naismith, Robert T.
    Negroski, Donald
    Oh, Jiwon
    Perez, Miguel Angel Hernandez
    Selmaj, Krzysztof
    Bergh, Florian Then
    Wundes, Annette
    Ziemssen, Tjalf
    Castro-Borrero, Wanda
    Chen, Hailu
    Levin, Seth
    Scaramozza, Matthew
    Shankar, Sai L.
    Wang, Ting
    Wray, Sibyl
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (14) : 1795 - 1807
12345